Novel Interactions Involving the Mas Receptor Show Potential of the Renin–Angiotensin system in the Regulation of Microglia Activation: Altered Expression in Parkinsonism and Dyskinesia
出版年份 2021 全文链接
标题
Novel Interactions Involving the Mas Receptor Show Potential of the Renin–Angiotensin system in the Regulation of Microglia Activation: Altered Expression in Parkinsonism and Dyskinesia
作者
关键词
-
出版物
Neurotherapeutics
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-01-21
DOI
10.1007/s13311-020-00986-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Structural basis of receptor recognition by SARS-CoV-2
- (2020) Jian Shang et al. NATURE
- The hallmarks of COVID-19 disease
- (2020) Daolin Tang et al. PLoS Pathogens
- COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia
- (2020) Luke Dixon et al. Neurology-Neuroimmunology & Neuroinflammation
- Expression of GPR55 and either cannabinoid CB1 or CB2 heteroreceptor complexes in the caudate, putamen, and accumbens nuclei of control, parkinsonian, and dyskinetic non-human primates
- (2020) Eva Martínez-Pinilla et al. Brain Structure & Function
- Potential neuroinvasive pathways of SARS‐CoV‐2: Deciphering the spectrum of neurological deficit seen in coronavirus disease‐2019 (COVID‐19)
- (2020) Abdul Mannan Baig et al. JOURNAL OF MEDICAL VIROLOGY
- Angiotensin-(1-7) and Alamandine Promote Anti-inflammatory Response in Macrophages In Vitro and In Vivo
- (2019) Melissa de Carvalho Santuchi et al. MEDIATORS OF INFLAMMATION
- The role of receptor MAS in microglia-driven retinal vascular development
- (2019) S. Foulquier et al. ANGIOGENESIS
- Correlation between angiotensin 1–7-mediated Mas receptor expression with motor improvement, activated STAT3/SOCS3 cascade, and suppressed HMGB-1/RAGE/NF-κB signaling in 6-hydroxydopamine hemiparkinsonian rats
- (2019) Mostafa A. Rabie et al. BIOCHEMICAL PHARMACOLOGY
- Angiotensin type 2 receptors: Role in aging and neuroinflammation in the substantia nigra
- (2019) Ana I. Rodriguez-Perez et al. BRAIN BEHAVIOR AND IMMUNITY
- Molecular and functional interaction between GPR18 and cannabinoid CB 2 G-protein-coupled receptors. Relevance in neurodegenerative diseases
- (2018) Irene Reyes-Resina et al. BIOCHEMICAL PHARMACOLOGY
- Cross-communication between Gi and Gs in a G-protein-coupled receptor heterotetramer guided by a receptor C-terminal domain
- (2018) Gemma Navarro et al. BMC BIOLOGY
- Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB 1 and CB 2 receptors and relevance for Alzheimer’s disease and levodopa-induced dyskinesia
- (2018) Gemma Navarro et al. BRAIN BEHAVIOR AND IMMUNITY
- The depressor axis of the renin–angiotensin system and brain disorders: a translational approach
- (2018) Mariela M. Gironacci et al. CLINICAL SCIENCE
- Dimerization of AT2 and Mas Receptors in Control of Blood Pressure
- (2018) Sanket Patel et al. CURRENT HYPERTENSION REPORTS
- Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death
- (2018) Ana I. Rodriguez-Perez et al. Neurotherapeutics
- Adenosine A2A receptor ligand recognition and signaling is blocked by A2B receptors
- (2018) Sonja Hinz et al. Oncotarget
- Anti-inflammatory effects of Ang-(1–7) via TLR4-mediated inhibition of the JNK/FoxO1 pathway in lipopolysaccharide-stimulated RAW264.7 cells
- (2018) Mei Jiang et al. DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY
- Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson’s disease
- (2017) Santiago Perez-Lloret et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Evidence for Heterodimerization and Functional Interaction of the Angiotensin Type 2 Receptor and the Receptor MASNovelty and Significance
- (2017) Julia Leonhardt et al. HYPERTENSION
- Paracrine and Intracrine Angiotensin 1-7/Mas Receptor Axis in the Substantia Nigra of Rodents, Monkeys, and Humans
- (2017) Maria A. Costa-Besada et al. MOLECULAR NEUROBIOLOGY
- Beneficial effects of Angiotensin II receptor blockers in brain disorders
- (2017) J.M. Saavedra PHARMACOLOGICAL RESEARCH
- Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration
- (2017) Jose L. Labandeira-Garcia et al. Frontiers in Aging Neuroscience
- Andy’s Algorithms: new automated digital image analysis pipelines for FIJI
- (2017) Andrew M. K. Law et al. Scientific Reports
- Quaternary structure of a G-protein-coupled receptor heterotetramer in complex with Gi and Gs
- (2016) Gemma Navarro et al. BMC BIOLOGY
- Basic Pharmacological and Structural Evidence for Class A G-Protein-Coupled Receptor Heteromerization
- (2016) Rafael Franco et al. Frontiers in Pharmacology
- Dopamine D2 and angiotensin II type 1 receptors form functional heteromers in rat striatum
- (2015) E. Martínez-Pinilla et al. BIOCHEMICAL PHARMACOLOGY
- 2′,3′-cAMP, 3′-AMP, 2′-AMP and adenosine inhibit TNF-α and CXCL10 production from activated primary murine microglia via A2A receptors
- (2015) Elizabeth A. Newell et al. BRAIN RESEARCH
- Angiotensin type 2 receptor (AT2R) and receptor Mas: a complex liaison
- (2015) Daniel Villela et al. CLINICAL SCIENCE
- Chronic Brain Inflammation: The Neurochemical Basis for Drugs to Reduce Inflammation
- (2015) Bevyn Jarrott et al. NEUROCHEMICAL RESEARCH
- Alternatively activated microglia and macrophages in the central nervous system
- (2015) Rafael Franco et al. PROGRESS IN NEUROBIOLOGY
- Alamandine
- (2014) Daniel C. Villela et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1β
- (2014) Ana Muñoz et al. EXPERIMENTAL NEUROLOGY
- l-DOPA disrupts adenosine A2A–cannabinoid CB1–dopamine D2 receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies
- (2014) Annalisa Pinna et al. EXPERIMENTAL NEUROLOGY
- Angiotensin II Mediates Angiotensin Converting Enzyme Type 2 Internalization and Degradation Through an Angiotensin II Type I Receptor–Dependent Mechanism
- (2014) Matthew R. Deshotels et al. HYPERTENSION
- Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia
- (2014) Daniel Farré et al. MOLECULAR NEUROBIOLOGY
- Aging-related dysregulation of dopamine and angiotensin receptor interaction
- (2014) Begoña Villar-Cheda et al. NEUROBIOLOGY OF AGING
- Receptor Mas Protects Mice Against Hypothermia and Mortality Induced By Endotoxemia
- (2014) Laura L. Souza et al. SHOCK
- Brain and retinal microglia in health and disease: An unrecognized target of the renin-angiotensin system
- (2013) Claudia A McCarthy et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Dopamine-Angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease
- (2013) Jose L. Labandeira-Garcia et al. MOVEMENT DISORDERS
- A1R–A2AR heteromers coupled to Gs and Gi/0 proteins modulate GABA transport into astrocytes
- (2013) Sofia Cristóvão-Ferreira et al. Purinergic Signalling
- Adenosine A2A–cannabinoid CB1 receptor interaction: An integrative mechanism in striatal glutamatergic neurotransmission
- (2012) Maria Teresa Tebano et al. BRAIN RESEARCH
- Brain renin–angiotensin system in the nexus of hypertension and aging
- (2012) Amy C Arnold et al. HYPERTENSION RESEARCH
- Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease
- (2012) K. Elisabet Ohlin et al. NEUROIMAGE
- NCS-1 associates with adenosine A2A receptors and modulates receptor function
- (2012) Gemma Navarro et al. Frontiers in Molecular Neuroscience
- Heteromerization of angiotensin receptors changes trafficking and arrestin recruitment profiles
- (2011) Enzo R. Porrello et al. CELLULAR SIGNALLING
- Angiotensin-Converting Enzyme 2: The First Decade
- (2011) Nicola E. Clarke et al. International Journal of Hypertension
- Location of Prorenin Receptors in Primate Substantia Nigra: Effects on Dopaminergic Cell Death
- (2010) Rita Valenzuela et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Aging-related changes in the nigral angiotensin system enhances proinflammatory and pro-oxidative markers and 6-OHDA-induced dopaminergic degeneration
- (2010) Begoña Villar-Cheda et al. NEUROBIOLOGY OF AGING
- Increased Abundance of Opioid Receptor Heteromers After Chronic Morphine Administration
- (2010) A. Gupta et al. Science Signaling
- Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors
- (2009) Carla Ferrada et al. BRITISH JOURNAL OF PHARMACOLOGY
- Systemic candesartan reduces brain angiotensin II via downregulation of brain renin–angiotensin system
- (2009) Nicolas Pelisch et al. HYPERTENSION RESEARCH
- Building a new conceptual framework for receptor heteromers
- (2009) Sergi Ferré et al. Nature Chemical Biology
- Differential Cannabinoid Receptor Expression during Reactive Gliosis: a Possible Implication for a Nonpsychotropic Neuroprotection
- (2009) Daniele De Filippis et al. TheScientificWorldJOURNAL
- Functional interactions between 7TM receptors in the Renin-Angiotensin System—Dimerization or crosstalk?
- (2008) Christina Lyngsø et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Detection of heteromerization of more than two proteins by sequential BRET-FRET
- (2008) Paulina Carriba et al. NATURE METHODS
- Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS
- (2008) J. Rodriguez-Pallares et al. NEUROBIOLOGY OF DISEASE
- Looking for the role of cannabinoid receptor heteromers in striatal function
- (2008) Sergi Ferré et al. NEUROPHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started